<?xml version="1.0" encoding="utf-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
<title>Legal Insider Trading Data | Free and Professional Subscription Services | Insider Insights</title>
<link href="http://www.insiderinsights.com/news/company/allo" ></link>
<id>urn:uuid:f03b7aed-fb71-7db8-19e7-d1490c647622</id>
<updated>2026-04-22T02:25:55-04:00</updated>
<author>Jonathan Moreland</author>
<subtitle>Profit from legal insider trading. InsiderInsights.com provides free insider trading data tools and resources, and professional grade subscription based real time Form 4 data, analysis and services</subtitle>
<entry>
<title>ALLO: BENESKI BENJAMIN MACHINAS (VP,CTO) Sold (S) 2,867 Shares of ALLOGENE THERAPEUTICS INC for $2.50 on 3/31</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6379372" ></link>
<id>urn:uuid:a5a0f253-3e8a-08f0-1ac7-89a2deb8c727</id>
<updated>2026-04-02T16:47:39-04:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
<entry>
<title>ALLO: BENESKI BENJAMIN MACHINAS (VP,CTO) Sold (S) 4,835 Shares of ALLOGENE THERAPEUTICS INC for $2.47 on 3/16</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6368881" ></link>
<id>urn:uuid:db60fba6-afdc-a98f-96aa-157ef62a88a3</id>
<updated>2026-03-18T16:06:54-04:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
<entry>
<title>ALLO: CHANG DAVID D (PR,CEO,DIR) Sold (S) 47,763 Shares of ALLOGENE THERAPEUTICS INC for $2.47 on 3/16</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6368873" ></link>
<id>urn:uuid:3b7bd6cd-98f7-6640-dfb4-21ced0e68b9c</id>
<updated>2026-03-18T16:05:48-04:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
<entry>
<title>ALLO: BENESKI BENJAMIN MACHINAS (VP,CTO) Sold (S) 7,132 Shares of ALLOGENE THERAPEUTICS INC for $2.60 on 3/2</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6352008" ></link>
<id>urn:uuid:3707e774-4a5f-8f31-4219-1b2928f2ce16</id>
<updated>2026-03-04T17:42:16-05:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
<entry>
<title>ALLO: BENESKI BENJAMIN MACHINAS (VP,CTO) Sold (S) 7,549 Shares of ALLOGENE THERAPEUTICS INC for $1.73 on 2/2</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6319687" ></link>
<id>urn:uuid:818dbecc-6309-e748-20b8-dd397b9db9e4</id>
<updated>2026-02-04T17:20:22-05:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
<entry>
<title>ALLO: CHANG DAVID D (PR,CEO,DIR) Sold (S) 95,269 Shares of ALLOGENE THERAPEUTICS INC for $1.80 on 2/2</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6319682" ></link>
<id>urn:uuid:69d28d99-6fef-eb70-be41-e3924df151a9</id>
<updated>2026-02-04T17:18:18-05:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
<entry>
<title>ALLO: PARKER GEOFFREY M (CFO) Sold (S) 24,001 Shares of ALLOGENE THERAPEUTICS INC for $1.76 on 2/2</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6319678" ></link>
<id>urn:uuid:f2c5d1c5-9439-4257-d6bd-3d0a2de2ade2</id>
<updated>2026-02-04T17:16:19-05:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
<entry>
<title>ALLO: DOUGLAS EARL MARTIN (VP,GC) Sold (S) 22,900 Shares of ALLOGENE THERAPEUTICS INC for $1.76 on 2/2</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6319670" ></link>
<id>urn:uuid:4daf9c15-3e8b-31f7-4951-0db155f79d19</id>
<updated>2026-02-04T17:12:18-05:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
<entry>
<title>ALLO: YOSHIYAMA ANNIE (VP,FO) Sold (S) 4,167 Shares of ALLOGENE THERAPEUTICS INC for $1.72 on 2/2</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6319668" ></link>
<id>urn:uuid:50342bba-1ff8-fccc-70a1-b6f0615c5270</id>
<updated>2026-02-04T17:09:39-05:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
<entry>
<title>ALLO: ROBERTS ZACHARY (VP) Sold (S) 35,700 Shares of ALLOGENE THERAPEUTICS INC for $1.77 on 2/2</title>
<link href="http://www.insiderinsights.com/company/allo/allogene-therapeutics-inc/id-6319663" ></link>
<id>urn:uuid:318827d3-1190-5158-1647-d7a6aa460749</id>
<updated>2026-02-04T17:07:38-05:00</updated>
<summary type="html" ><![CDATA[ALLOGENE THERAPEUTICS INC (ALLO). Recent Price: $2.39. Mkt Cap:791.8mm. 10D Vol: 26.9mm]]></summary>
</entry>
</feed>